BG
WVE icon

Bellevue Group’s Wave Life Sciences WVE Stock Holding History

Bellevue Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,261
Closed -$38.1K – 169
2026
Q1 		$38.1K Sell
5,261
-1,485,257
-100% -$19.3M ﹤0.01% 150
2025
Q4 		$25.3M Sell
1,490,518
-2,603,940
-64% -$26.5M 0.48% 44
2025
Q3 		$30M Hold
4,094,458
– – 0.62% 38
2025
Q2 		$26.6M Hold
4,094,458
– – 0.59% 44
2025
Q1 		$33.1M Hold
4,094,458
– – 0.74% 31
2024
Q4 		$50.6M Hold
4,094,458
– – 0.97% 25
2024
Q3 		$33.6M Hold
4,094,458
– – 0.54% 55
2024
Q2 		$20.4M Hold
4,094,458
– – 0.33% 71
2024
Q1 		$25.3M Sell
4,094,458
-400,000
-9% -$2M 0.39% 72
2023
Q4 		$22.7M Hold
4,494,458
– – 0.35% 72
2023
Q3 		$25.8M Hold
4,494,458
– – 0.42% 68
2023
Q2 		$16.4M Hold
4,494,458
– – 0.23% 84
2023
Q1 		$19.5M Hold
4,494,458
– – 0.28% 82
2022
Q4 		$31.5M Hold
4,494,458
– – 0.42% 67
2022
Q3 		$16.2M Hold
4,494,458
– – 0.23% 90
2022
Q2 		$14.6M Sell
4,494,458
-68,400
-1% -$132K 0.21% 97
2022
Q1 		$9.13M Sell
4,562,858
-40,000
-0.9% -$98K 0.11% 107
2021
Q4 		$14.5M Buy
4,602,858
+2,000,000
+77% +$8.3M 0.15% 107
2021
Q3 		$12.8M Hold
2,602,858
– – 0.13% 109
2021
Q2 		$17.3M Hold
2,602,858
– – 0.17% 110
2021
Q1 		$14.6M Hold
2,602,858
– – 0.15% 111
2020
Q4 		$20.5M Hold
2,602,858
– – 0.23% 100
2020
Q3 		$22.1M Hold
2,602,858
– – 0.31% 83
2020
Q2 		$27.1M Hold
2,602,858
– – 0.38% 65
2020
Q1 		$24.4M Buy
2,602,858
+200,000
+8% +$1.7M 0.47% 58
2019
Q4 		$19.3M Buy
2,402,858
+850,000
+55% +$20.8M 0.31% 62
2019
Q3 		$31.9M Buy
1,552,858
+37,856
+2% +$868K 0.59% 44
2019
Q2 		$39.5M Buy
+1,515,002
New +$42.5M 0.67% 37

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Bellevue Group's WVE Position: Q2 2026 in Review

Bellevue Group sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 5,261 shares — an estimated $38.1K sold.

Bellevue Group first reported a position in WVE in Q2 2019 and held it in 28 quarters. The position peaked at $50.6M in Q4 2024. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Bellevue Group reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Bellevue Group sold 5,261 Wave Life Sciences shares in Q2 2026, an estimated $38.1K.
  • Bellevue Group first reported a position in Wave Life Sciences in Q2 2019 and held it in 28 quarters.
  • Bellevue Group's Wave Life Sciences position peaked at $50.6M in Q4 2024.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.